Colgate-Palmolive’s stock slips on weaker-than-expected guidance despite Q4 profit beat
Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.
The Fed’s go-to inflation gauge heated up again
The Federal Reserve’s preferred inflation gauge moved even higher in December, driven largely by rising energy prices as well ...
AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%
AbbVie Inc.’s stock rose 5% early Friday to lead S&P 500 gainers premarket, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology ...
Why the SEC might have an issue with Southwest's earnings
Southwest Airlines Co. may be at risk of a comment letter from the Securities and Exchange Commission after including adjusted revenue in its fourth-quarter earnings report published early Thursday.